Skip to main content
. Author manuscript; available in PMC: 2013 Dec 12.
Published in final edited form as: Leuk Lymphoma. 2013 Jan 24;54(9):10.3109/10428194.2012.760733. doi: 10.3109/10428194.2012.760733

Table I.

Patient characteristics

Patient characteristic Result

Median Age (years) 63 years (range, 43-77)

Male/Female (n) 6/5

AML rising from AHD (n) 4

t-AML (n) 1

Refractory AML (n) 4

Relapsed AML (n) 7

ELN* genetic group
    Intermediate II 7
    Adverse 4

Prior anthracycline exposure (n) 10

Median number prior regimens (n) 2 (range, 1-4)

AHD, antecedent hematologic disorder, t-AML, therapy-related AML,

*

See ref.32